Sim, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A used to treat atherosclerotic diseases, has protective effects on bleomycin-induced pulmonary fibrosis in rats by reducing the levels of IL-13 and TGF-β1 [43]. Here, TGFB1 is linked to pulmonary fibrosis.